Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)

Fortrea Holdings (FTRE) posted Total Liabilities of $2.2 billion for Q1 2026, little changed on a QoQ basis from $2.2 billion in Q4 2025, and down 4.63% year-over-year from $2.3 billion in Q1 2025.

Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings' Total Liabilities history runs 5 years deep, the most recent figure standing at $2.2 billion for Q1 2026.

  • Quarterly Total Liabilities fell 4.63% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (down 4.63% YoY) and the FY2025 annual result came in at $2.2 billion, down 2.91% from the prior year.
  • Total Liabilities was $2.2 billion for Q1 2026 at Fortrea Holdings, roughly flat from $2.2 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $2.6 billion in Q1 2024 and bottomed at $945.3 million in Q4 2022.
  • A 5-year average of $2.2 billion and a median of $2.2 billion in 2024 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2023 — Total Liabilities surged 177.0% — and 2024, when it dropped 19.22%.
  • Fortrea Holdings' Total Liabilities stood at $945.3 million in 2022, then soared by 177.0% to $2.6 billion in 2023, then decreased by 15.34% to $2.2 billion in 2024, then decreased by 2.91% to $2.2 billion in 2025, then grew by 0.25% to $2.2 billion in 2026.
  • Business Quant data shows FTRE's Total Liabilities at $2.2 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 2.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.16 Bn
Dec 31, 2025 2.15 Bn
Sep 30, 2025 2.16 Bn
Jun 30, 2025 2.25 Bn
Mar 31, 2025 2.26 Bn
Dec 31, 2024 2.22 Bn
Sep 30, 2024 2.15 Bn
Jun 30, 2024 2.10 Bn
Mar 31, 2024 2.65 Bn
Dec 31, 2023 2.62 Bn
Sep 30, 2023 2.62 Bn
Jun 30, 2023 2.61 Bn
Dec 31, 2022 945.30 Mn